Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04144426
Other study ID # 140536
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 8, 2015
Est. completion date May 26, 2017

Study information

Verified date October 2019
Source Vanderbilt University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will test will how eating on a particular daily schedule may effect energy, weight gain or loss, and body temperature.


Description:

Although there have been a large number of studies in humans on the effects of food intake at night, very few studies directly address the hypothesis that inappropriately phased eating or snacking (i.e., at night) in humans disrupts metabolism and respiratory quotient (RQ) patterns and there are no studies that we are aware of that directly measure circadian clock phase relative to timing of food intake while evaluating metabolism. This may be critical, because it is well established that the timing of food intake can also modulate circadian clock phase.

Hypothesis: Food consumption in the subjective night (e.g., 20:00 - 02:00) will result in a different circadian metabolic profile measured by RQ) than food consumed in the subjective day.

Aim 1: To determine if there are daily rhythms of switching between lipid and carbohydrate metabolism in humans that are altered by the timing of food intake. Aim 2: To determine if timing of food intake results in "internal desynchronization" between the metabolic rhythms (RQ) and the rhythm in core body temperature (a marker of central circadian phase).

Aim 3: To determine if body composition has measurable impact on the circadian regulation of metabolism.

In this study we will test human subjects in a specially designed whole-room indirect calorimeter where energy expenditure and RQ will be monitored by indirect calorimetry continuously over 56 hours. Circadian phase and amplitude will be assessed by continuously recording the core body temperature rhythm using the Vital Sense Integrated Physiological Monitoring System in which subjects swallow a telemetry capsule that transmits core body temperature to a data acquisition module. In consultation with a nutritionist at Vanderbilt, we will use a cross-over design in which daily diets have the same caloric and nutritional value but in which the subjects consume the calories that would normally be breakfast as snacks consumed in the late-evening.


Recruitment information / eligibility

Status Completed
Enrollment 6
Est. completion date May 26, 2017
Est. primary completion date May 26, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 50 Years and older
Eligibility Inclusion Criteria:

- Be able to understand the study, provide written informed consent (in English), and be able to fill out the questionnaire

- Be male or female older than 18 years of age;

- Have a normal BMI (20-25) or be obese (BMI more than 30);

- Have a normal basal glucose level (70-100 mg/dL)

- If female of childbearing potential, have a negative pregnancy test on study day;

Exclusion Criteria:

- Be pregnant or lactating;

- Have known sleep, metabolic (e.g., diabetes), or gastro-intestinal disorders except obesity;

- Had alcohol less than 24 hours before admission;

- Require assistance with activities of daily living;

- Have difficulty swallowing

- Be unable to complete a food and sleep diary

- Be smokers

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Normal diet
Participants will receive either a 2000 calorie or a 2500 calorie diet at normal meal times
Modified diet
Participants will receive either a 2000 calorie or a 2500 calorie diet with a single meal shift, breakfast is moved to an hour before bedtime.

Locations

Country Name City State
United States Vanderbilt University Medical Center Nashville Tennessee

Sponsors (1)

Lead Sponsor Collaborator
Vanderbilt University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Oxygen intake Subjects were housed in a whole room calorimeter and oxygen consumption was monitored minute by minute 56 hours
Primary Carbon dioxide exhaled Subjects were housed in a whole room calorimeter and carbon dioxide was monitored minute by minute 56 hours
Primary Core body temperature The subjects' circadian phase and amplitude will be assessed by continuously recording the core body temperature rhythm with an ingestible Vital Sense monitor. 56 hours
Primary Locomotor activity The subject's activity will be assessed throughout the experiment using a Actigraph (GT3X) triaxial monitor attached to the subject's wrist, waist, and ankle. 56 hours
Secondary Determination of Body Mass Index (BMI) A dual-energy X-ray absorptiometry (DXA) scan will be performed to assess subject's percentage body fat after check-in and before the first night in the metabolic chamber. Fat content will be used to accurately determine the subject's Body Mass Index. Baseline just prior to entry in the metabolic chamber
See also
  Status Clinical Trial Phase
Completed NCT00070577 - Influence of Age and Sex on Alcohol Metabolism and Acute Responses N/A
Active, not recruiting NCT05488574 - Effects of Novel Breathing Behavior Modification Yoga Positioning Integrated Program on Weight Loss N/A
Recruiting NCT05582824 - Lactate Metabolism in the Hypoperfused Critically Ill
Recruiting NCT05443347 - Activity, Adiposity, and Appetite in Adolescents 2 Intervention N/A
Completed NCT05020808 - The Effect of a Plant Protein Isolate on Muscle Protein Synthesis in Humans at Rest and After Resistance Exercise N/A
Recruiting NCT06082726 - The Systemic Concentration of Short-Chain Fatty Acids After Delivery in the Small and Large Intestine of Healthy Volunteers N/A
Completed NCT03424395 - Personalized Dietary Program and Markers of Wellness N/A
Completed NCT02441296 - Carbohydrate and Metabolism: a Pilot Study N/A
Completed NCT00176085 - Pharmacokinetics of THCCOOH and Its Acyl-glucuronide After Intravenous Administration of THCCOOH Phase 1
Completed NCT00245986 - Effect of Genetics on Metabolism of Efavirenz Phase 4
Completed NCT04025346 - To Evaluate the Efficacy of Capsimax on Metabolic Rate N/A
Completed NCT04078646 - Influence of Proteins on the Bioavailability of Carotenoids N/A
Recruiting NCT06033898 - Inactivity Duration on Lipid Metabolism N/A
Recruiting NCT06250270 - Effects of Casein Protein on Metabolism When Taken Prior to Sleep and in the Morning Phase 1
Completed NCT06285578 - Effects of Probiotic and HIIT in Obese Women N/A
Completed NCT04255368 - Choline Source, Gut Microbiota and Trimethylamine-N-oxide Response N/A
Recruiting NCT06360796 - Study of Pharmacokinetics and Metabolism on [(14)C]ADC189 Phase 1
Recruiting NCT02005003 - Cognitive and Metabolic Effects of a Probiotic Supplement N/A
Completed NCT03146728 - Finding the Optimal Voluntary Exercise Parameters for Those Living With Quadriplegia N/A
Completed NCT00692510 - Drug Interaction Study Between AZD3480 and Cytochrome P450 Phase 1